Recovery & Healing
BPC-157
A gut-derived peptide studied for tendon, ligament, muscle and gut repair.
Also called: Body Protection Compound 157, pentadecapeptide BPC 157, BPC157
Used for
Recovery & Healing
Our pricing
$100 to $1,000+ depending on peptide and quantity
Studied for
Tendon and ligament healing · Gut lining and inflammatory bowel conditions
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. It is studied mainly for its effects on tendon, ligament, muscle and gut-lining repair, and patients who use it under supervision commonly describe a faster comeback from stubborn soft-tissue injuries; research is still catching up to what patients report. Access to BPC-157 through licensed pharmacies expanded in 2026; whether it fits you is decided at a consultation.
What is BPC-157?
BPC-157 is a fragment of a larger protective protein that the stomach produces naturally. Researchers isolated the 15-amino-acid sequence in the 1990s and have since tested it in hundreds of laboratory and animal studies, most of them from a single research group in Croatia.
In those models it appears to act on blood-vessel growth (angiogenesis), nitric-oxide signaling and growth-factor pathways involved in tissue repair. That mechanism is why it is discussed for injuries that heal slowly, such as tendons and ligaments, and for gut-lining problems.
Human trials are smaller than the real-world experience clinicians see week to week: published human data are limited to small case series and pilot studies, while patients using BPC-157 under supervision often describe meaningful, tangible relief in stubborn tendon, ligament and gut issues. No product containing it is FDA-approved, so it is offered as a compounded, off-label option guided by that real-world pattern.
What BPC-157 is studied for
The goals researchers and clinicians have focused on, and why patients ask about it.
Tendon and ligament healing
The most cited BPC-157 research involves rodent Achilles tendon, medial collateral ligament and muscle-crush injuries, where treated animals healed faster and with better tissue organization — a pattern that lines up with what many patients describe in their own recovery from nagging tendon and ligament injuries, even though controlled human trials haven't yet confirmed it.
Gut lining and inflammatory bowel conditions
Because it originates in gastric juice, BPC-157 has been studied for ulcers, colitis and gut-lining protection in animal models, and patients often report calmer digestion and less gut discomfort while using it under supervision. In July 2026 an FDA advisory committee reviewed it specifically for a proposed ulcerative-colitis use.
Muscle recovery and joint pain
Small human pilot reports, including intra-articular injections for knee pain, describe symptom improvement — a finding that echoes what many patients tell us about faster bounce-back after training and less lingering joint soreness, though those pilot studies were small and human research is still catching up to that real-world experience.
Nerve and blood-vessel repair
Animal studies suggest effects on nerve regeneration and vessel growth, an active research area that patients using BPC-157 for nerve-related discomfort often describe as a helpful part of their recovery plan.
The human side
What patients commonly report with BPC-157
Clinical trials move slowly; patient experience moves faster. Here is what people using BPC-157 under clinical supervision most often describe. Results vary from person to person.
Faster bounce-back after hard training or a nagging tendon or ligament injury
Less lingering joint and muscle soreness between workouts
Calmer digestion and less gut discomfort
A sense of steadier, more complete recovery when paired with physical therapy
How BPC-157 is typically used
When a clinician does use BPC-157, it is most often given as a small subcutaneous injection, sometimes near the injured area, with oral capsules also marketed for gut-focused goals. Protocols typically run in defined cycles of several weeks rather than continuously.
Any use should start with a health history, a conversation about what the evidence and patient experience each show, and a clear goal so progress can actually be judged. Dosing, route and duration are individual clinical decisions and are not published here.
BPC-157 is never a substitute for diagnosing the injury. Imaging, physical therapy, load management and, where appropriate, orthopedic referral come first.
Who tends to do well with it
Adults with a specific, diagnosed soft-tissue or gut-lining problem who have already tried standard care
Patients who want a defined cycle with a clinician alongside physical therapy or training
People already in a hormone or weight-loss program where recovery is a bottleneck
When we take extra care
Anyone with a history of cancer, because the peptide promotes blood-vessel growth and the long-term implications are unknown
Pregnant or breastfeeding patients (no safety data)
Competitive athletes: BPC-157 is prohibited by the World Anti-Doping Agency
Anyone considering research-chemical products bought online, which are unregulated and frequently mislabeled
What to know before you start
Long-term data are still being gathered, which is why we use defined cycles and check-ins.
The FDA has noted immunogenicity (immune reaction) and impurity considerations with compounded peptide products.
Injection-site redness, nausea, dizziness and headache are reported anecdotally.
Theoretical concern that pro-angiogenic effects could influence tumor growth.
Unregulated online products carry contamination, dosing and identity risks that a licensed pharmacy does not.
Where BPC-157 stands with the FDA
Access to BPC-157 through licensed compounding pharmacies reopened in 2026. After two years on the FDA's restricted-compounding list, it was removed in April 2026 following HHS Secretary Kennedy's February announcement, and on July 23, 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding it to the permanent 503A compounding list for an ulcerative-colitis use. That recommendation still has to go through FDA rulemaking, expected in 2027 or 2028. BPC-157 is not an FDA-approved finished drug; whether a licensed pharmacy can prepare it for you is confirmed at your consultation under the rules in force at that time.
Source: FDA compounding guidanceWhat BPC-157 typically costs
At Hormones + Weight Loss, peptide pricing runs from about $100 to $1,000 or more depending on the peptide and the quantity you order, and many patients start with a single peptide on a short cycle. Your exact cost is quoted after your consultation.
Injectable vs. oral form
Cycle length and whether it is combined with other peptides
Pharmacy sourcing and whether a consultation and labs are bundled
Often combined with
Peptides are an add-on, not a plan. At Hormones + Weight Loss they are considered inside a broader, lab-guided program.
BPC-157 FAQs
BPC-157 is studied for speeding tendon, ligament, muscle and gut-lining repair by influencing blood-vessel growth and repair signaling, and patients commonly report a faster comeback from stubborn injuries and calmer digestion. Most published evidence comes from animal studies, and human research is still catching up to what patients report, so it's offered as a supervised, off-label option.
It can be prescribed and compounded by licensed pharmacies again as of 2026: the FDA removed it from its restricted list in April, and an FDA advisory committee recommended it for the permanent compounding list in July. It is not an FDA-approved finished drug and the final rule is pending, so what a pharmacy can prepare is confirmed at your visit. Research-chemical purchases are a different, unregulated market.
Most protocols use small subcutaneous injections, sometimes near the injured area; oral capsules are marketed for gut goals. Courses usually run a set number of weeks. Route, dose and duration are individual decisions made with your nurse practitioner.
Reported effects are mostly mild: injection-site irritation, nausea, dizziness or headache. Long-term data in people are still being gathered, which is why we use defined cycles and follow-up visits, and the FDA has noted immune-reaction and purity considerations for compounded peptides generally.
Peptide therapy at Hormones + Weight Loss ranges from about $100 to $1,000 or more, depending on the peptide and the quantity ordered. Where BPC-157 lands inside that range depends on the form, the cycle length and whether it is combined with other care. Your exact cost is quoted after your consultation and labs.
Hormones + Weight Loss discusses peptide options, including BPC-157, at our Meridian, Twin Falls and Lewiston clinics, with Boise-area patients seen in Meridian. A consultation with a nurse practitioner determines whether any peptide fits your goals and can be prescribed under current rules.
Not if you compete under anti-doping rules. BPC-157 is on the World Anti-Doping Agency prohibited list as a non-approved substance. Tested athletes should not use it.
Related peptides
Recovery & Healing
TB-500
A thymosin beta-4 fragment studied in animals for wound, tendon and muscle repair.
Skin, Hair & Anti-Aging
GHK-Cu
A naturally occurring copper peptide studied for collagen, wound healing and skin appearance.
Growth-Hormone Support
Sermorelin
A GHRH analog studied for prompting your own pituitary to release growth hormone.
Peptide therapy near you in Idaho
Consultations at all three clinics. Boise-area patients are seen at our Meridian clinic, minutes off Eagle Road and I-84.
Meridian
2572 N Stokesberry Pl #300
Meridian, ID 83646
Mon–Fri 8am–6pm
Twin Falls
496 Shoup Ave West Ste E
Twin Falls, ID 83301
Mon–Thu 8am–6pm
Lewiston
1630 23rd Ave Ste 1201A
Lewiston, ID 83501
Mon–Wed 8am–6pm
Educational content only. It does not replace an evaluation by a licensed clinician. Whether a peptide fits you is decided at your consultation.
Wondering whether BPC-157 fits your goals?
Start with a consultation and labs. A nurse practitioner will walk through the evidence, the current rules, and whether any peptide belongs in your plan.